NCT03292289Completed
Assessment of Symptoms and Consequences of Coloanal Continuity Reconstruction
Assessment of Symptoms and Their Consequences on Patients Quality of Life After Coloanal Continuity Reconstruction Following a Proctectomy for Rectal Cancer
Source: ClinicalTrials.gov · Last updated 17 Mar 2026
Brief summary (registry, in English)
This study is a prospective, monocentric study whose aim is to assess the quality of life for patients who underwent a coloanal continuity reconstruction and to understand the functional issues they encounter. This will potentially provide predictive factors identification of bad functional outcomes allowing to guide future decisions. Also, it will allow patients to have a reinforced follow-up during the year after the reconstruction.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 65 (actual)
- First submitted
- 18 Sept 2017
- Start date
- 18 Jan 2018
- Primary completion date
- 29 Jul 2024
- Lead sponsor
- Centre Oscar Lambret
- Diseases
- Colorectal cancer
- NCT number
- NCT03292289
What you commit to
- Study type: Interventional
- Participants enrolled: 65
- From 18 Jan 2018 to the primary completion date, 29 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unwilling patients
- Patient deprived of their liberty or under guardianship or tutorship.
- Abdominal perineal amputation
- No stoma placement planned
- Tumor more than 15 cm from the anal margin
Who the study is looking for
- 18 to 70 years old
- Patients who are going to undergo a proctectomy for a rectal cancer (situated at a distance equal or lower to 15 cm from the anoderm) following by a coloanal continuity reconstruction (using direct, latero-terminal or colonic J-pouch anastomosis)
- Already underwent or not a neoadjuvant radio-chemotherapy
- Affiliation to the National Social Security System
- With informed and signed consent
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Oscar Lambret Coordinator of this site? Confirm its status | Lille | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.